Triple Therapy of Vitrectomy, Intravitreal Triamcinolone, and Macular Laser Photocoagulation for Intractable Diabetic Macular Edema

American Journal of Ophthalmology

Volumn 144, Issue 6, 2007, Pages

  Kang, Se Woong ^a   Park, Sung Chul ^a   Cho, Hee Yoon ^b   Kang, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CATARACT; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LASER COAGULATION; MALE; PRIORITY JOURNAL; VISION; VITRECTOMY;

EID: 36248942604     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.07.044     Document Type: Article

References (35)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report no. 1. Arch Ophthalmol 103 (1985) 1796-1806
2. Bresnick G.H. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology 90 (1983) 1301-1317
3. Lee C.M., and Olk R.J. Modified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual results. Ophthalmology 98 (1991) 1594-1602
4. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
5. Funatsu H., Yamashita H., Sakata K., et al. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 112 (2005) 806-816
6. Bonini-Filho M.A., Jorge R., Barbosa J.C., Calucci D., Cardillo J.A., and Costa R.A. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci 46 (2005) 3845-3849
7. Jonas J.B., Spandau U.H., Kamppeter B.A., Vossmerbaeumer U., Harder B., and Sauder G. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 113 (2006) 800-804
8. Cunningham Jr. E.T., Adamis A.P., Altaweel M., et al., Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 (2005) 1747-1757
9. Lewis H., Abrams G.W., Blumenkranz M.S., and Campo R.V. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99 (1992) 753-759
10. Stolba U., Binder S., Gruber D., Krebs I., Aggermann T., and Neumaier B. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140 (2005) 295-301
11. Mochizuki Y., Hata Y., Enaida H., et al. Evaluating adjunctive surgical procedures during vitrectomy for diabetic macular edema. Retina 26 (2006) 143-148
12. Recchia F.M., Ruby A.J., and Carvalho Recchia C.A. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol 139 (2005) 447-454
13. Yanyali A., Nohutcu A.F., Horozoglu F., and Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol 139 (2005) 795-801
14. Parolini B., Panozzo G., Gusson E., et al. Diode laser, vitrectomy and intravitreal triamcinolone. A comparative study for the treatment of diffuse non tractional diabetic macular edema. Semin Ophthalmol 19 (2004) 1-12
15. Massin P., Duguid G., Erginay A., Haouchine B., and Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135 (2003) 169-177
16. Thomas D., Bunce C., Moorman C., and Laidlaw D.A. A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema. Br J Ophthalmol 89 (2005) 81-86
17. Patel J.I., Hykin P.G., Schadt M., et al. Diabetic macular oedema: pilot randomized trial of pars plana vitrectomy vs macular argon photocoagulation. Eye 20 (2006) 873-881
18. Patel J.I., Hykin P.G., Schadt M., Luong V., Fitzke F., and Gregor Z.J. Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26 (2006) 5-13
19. Kimura T., Kiryu J., Nishiwaki H., et al. Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina 25 (2005) 454-461
20. Kang S.W., Sa H., Cho H.Y., and Kim J.I. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol 124 (2006) 653-658
21. Zacks D.N., and Johnson M.W. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy. Retina 25 (2005) 135-140
22. Kang S.W., Park C.Y., and Ham D.I. The correlation between fluorescein angiographic and optical coherence tomographic feature in clinically significant diabetic macular edema. Am J Ophthalmol 137 (2004) 313-322
23. Shah S.P., Patel M., Thomas D., Aldington S., and Laidlaw D.A. Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol 90 (2006) 33-36
24. Inoue M., Nagai N., Shinoda H., Shinoda K., Kitamura S., and Oguchi Y. Intravitreal injection of triamcinolone acetonide for cystoid macular edema resistant to vitreous surgery. Nippon Ganka Gakkai Zasshi 108 (2004) 92-97
25. Wallow I.H. Repair of the pigment epithelial barrier following photocoagulation. Arch Ophthalmol 102 (1984) 126-135
26. Weiter J.J., and Zuckerman R. The influence of photoreceptor-RPE complex on the inner retina; an explanation for beneficial effects of photocoagulation. Ophthalmology 87 (1980) 1133-1139
27. Avitabile T., Longo A., and Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 140 (2005) 695-702
28. Stefansson E., Novack R.L., and Hatchell D.L. Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31 (1990) 284-289
29. Funatsu H., Yamashita H., Ikeda T., Mimura T., Shimizu E., and Hori S. Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol 135 (2003) 321-327
30. Matsunaga N., Ozeki H., Hirabayashi Y., Shimada S., and Ogura Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 25 (2005) 311-316
31. Beer P.M., Bakri S.J., Singh R.J., Liu W., Peters III G.B., and Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110 (2003) 681-686
32. Chin H.S., Park T.S., Moon Y.S., and Oh J.H. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 25 (2005) 556-560
33. Chun D.W., Heier J.S., Topping T.M., Duker J.S., and Bankert J.M. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 113 (2006) 1706-1712
34. Storkebaum E., Lambrechts D., and Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26 (2004) 943-954
35. Kilic U., Kilic E., Jarve A., et al. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 26 (2006) 12439-12446